Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources
Elvanse (redirect)
See parent — vyvanse.md | Compound
Aliases (9)
Vyvanse (US/CA/AU) · Lisdexamfetamine · Lisdexamfetamine Dimesylate · LDX · Tyvense (IE) · Venvanse (BR) · Aduvanz · NRP-104 · L-lysine-d-amphetamine
TYPICAL DOSE
—
ROUTE
—
CYCLE
—
STORAGE
—
✎
Suggest an edit
Did you know?
You can suggest edits to improve this compound's information.
Submitted via email — no account required.
▸ Overview TL;DR
This file is a stub. The canonical entry is vyvanse.md.
▸ Pharmacokinetics No data
Pharmacokinetics data not available for this compound.
No half-life mentions found in the source notes.
▸ What to expect Generic
- 1Week 1Tolerability and dose-response.
- 2Week 2-4Early effect window.
- 3Week 4-8Peak benefit assessment.
- 4Week 8+Cycle decision point.
▸References2 sources
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources
Related compounds
Cross-referenced from Elvanse (redirect)Vyvanse
SKIP-FOR-NOW
Amphetamine prodrug — long-acting d-amphetamine delivered via L-lysine peptide bond, cleaved by RBC aminopeptidase
MEDIUM
Adderall
SKIP-FOR-NOW
Amphetamine — substituted phenethylamine releasing agent (SNDRA)
MEDIUM
Dexedrine
SKIP-FOR-NOW
Amphetamine — pure dextrorotatory enantiomer (no L-isomer)
MEDIUM
Modafinil
PRIMARY-PICK
Eugeroic — wakefulness-promoting agent (atypical CNS stimulant)
HIGH
Focalin (Dexmethylphenidate)
SKIP-FOR-NOW
Methylphenidate-class CNS stimulant (d-isomer of racemic methylphenidate)
MEDIUM